gbr 12935 has been researched along with quinidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, T; Funae, Y; Hiroi, T; Imaoka, S; Yabusaki, Y | 1 |
| Allard, P; Norlén, M | 1 |
2 other study(ies) available for gbr 12935 and quinidine
| Article | Year |
|---|---|
Specific binding of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl propyl) piperazine (GBR-12935), an inhibitor of the dopamine transporter, to human CYP2D6.
Topics: Carrier Proteins; Cytochrome P-450 CYP2D6; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gene Expression; Humans; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Mitochondria; Nerve Tissue Proteins; Piperazines; Quinidine; Quinine; Saccharomyces cerevisiae | 1997 |
[3H]GBR 12935 binding in platelets: a possible association with cytochrome P-450IID6?
Topics: Antipsychotic Agents; Blood Platelets; Culture Techniques; Cytochrome P-450 Enzyme System; Dopamine Antagonists; Enzyme Inhibitors; Flupenthixol; Humans; Ligands; Lobeline; Piperazines; Piperidines; Quinidine | 1997 |